PASSAGE BIO INC. - CO
0.6210
25-十一月-24 15:45:01
15 分钟延时
股票
+0.1160
+22.97%
今日范围
0.4709 - 0.6900
ISIN
N/A
来源
NASDAQ
-
18 5月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
16 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
Passage Bio to Report First Quarter 2022 Financial Results on May 16, 2022
09 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
03 5月 2022 13:13:24 条件 Nasdaq GlobeNewswire
-
02 5月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
22 4月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
29 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming Investor Conferences
28 3月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Passage Bio Provides Update on Strategic Priorities and Extends Cash Runway
15 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
10 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
03 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming March Investor Conferences
01 3月 2022 06:00:03 条件 Nasdaq GlobeNewswire
-
Passage Bio to Report Fourth Quarter and Full-Year 2021 Financial Results on March 3, 2022
24 2月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
11 2月 2022 10:00:00 条件 Nasdaq GlobeNewswire
-
31 1月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
10 1月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
Passage Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
03 1月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
17 12月 2021 06:00:00 条件 Nasdaq GlobeNewswire
-
Passage Bio Announces Pipeline Expansion and Clinical Program Update
08 12月 2021 06:00:00 条件 Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
19 11月 2021 15:00:00 条件 Nasdaq GlobeNewswire